3-aminobenzamide has been researched along with Esophageal Squamous Cell Carcinoma in 1 studies
Esophageal Squamous Cell Carcinoma: A carcinoma that originates usually from cells on the surface of the middle and lower third of the ESOPHAGUS. Tumor cells exhibit typical squamous morphology and form large polypoid lesions. Mutations in RNF6, LZTS1, TGFBR2, DEC1, and WWOX1 genes are associated with this cancer.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakogawa, K | 1 |
| Aoki, Y | 1 |
| Misumi, K | 1 |
| Hamai, Y | 1 |
| Emi, M | 1 |
| Hihara, J | 1 |
| Shi, L | 1 |
| Kono, K | 1 |
| Horikoshi, Y | 1 |
| Sun, J | 1 |
| Ikura, T | 1 |
| Okada, M | 1 |
| Tashiro, S | 1 |
1 other study available for 3-aminobenzamide and Esophageal Squamous Cell Carcinoma
| Article | Year |
|---|---|
Involvement of homologous recombination in the synergism between cisplatin and poly (ADP-ribose) polymerase inhibition.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Benzamides; Carcinoma, Squamous Cell; Cell L | 2013 |